Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing new Tapestri Platform updates including lowered input threshold and expanded heme-onc menu. Learn More
X
publication

A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN


Xiao, W. et al.
Blood Advances (2020)
Abstract

  • Myeloid neoplasm (MPN) clones can evolve from acute myeloid leukemia to gain dominance with isocitrate dehydrogenase inhibition.
  • Pro-differentiation agents such as ivosidenib can unmask MPN sequelae.



Authors

Xiao, W., Miles, L.A.., Bowman R.L., Durani, V., Tian H.S., DelGaudio, N.L., Mishra, T., Zhu, M. Zhang, Y., Stump, S.E.., Tallman, M.S., Levine, R.L.., Cai, S.F.



VIEW

publication
Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue
Sharma R
Blood (2021)
publication
Diverse alterations associated with resistance to KRAS(G12C) inhibition
Zhao Y
Nature (2021)
publication
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
Sahoo S.S.
Nature Medicine (2021)
publication
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
Marin-Bejar, O.
Cancer Cell (2021)
REQUEST QUOTE